Rachel M Shaffer1, Kelly K Ferguson2, Lianne Sheppard3, Tamarra James-Todd4, Samantha Butts5, Suchitra Chandrasekaran6, Shanna H Swan7, Emily S Barrett8, Ruby Nguyen9, Nicole Bush10, Thomas F McElrath11, Sheela Sathyanarayana12. 1. Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA. Electronic address: rms14@uw.edu. 2. Epidemiology Branch, Intramural Research Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA. 3. Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA; Department of Biostatistics, University of Washington, Seattle, WA, USA. 4. Departments of Environmental Health and Epidemiology, Harvard School of Public Health, Boston, MA, USA; Division of Women's Health, Department of Medicine, Connors Center for Women's Health and Gender Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. 5. Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, PA, USA. 6. Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, University of Washington, Seattle, WA, USA. 7. Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 8. Department of Epidemiology, Environmental and Occupational Health Sciences Institute, Rutgers School of Public Health, Piscataway, NJ, USA. 9. Department of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN, USA. 10. Department of Psychiatry and Pediatrics, University of California San Francisco, San Francisco, CA, USA. 11. Division of Maternal-Fetal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. 12. Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA; Seattle Children's Research Institute, Seattle, WA, USA.
Abstract
BACKGROUND: Phthalates are common plasticizer chemicals that have been linked to glucose intolerance in the general population, but there is only limited research on their association with gestational diabetes (GDM). OBJECTIVE: We evaluated the association between 11 urinary phthalate metabolites and GDM, impaired glucose tolerance (IGT), and continuous blood glucose concentration during pregnancy in The Infant Development and Environment Study (TIDES). Based on prior study results, our primary analyses focused on monoethyl phthalate (MEP) in relation to our outcomes of interest. STUDY DESIGN: We used multi-variable logistic regression to examine the odds of GDM and IGT in relation to an interquartile-range (IQR) increase in natural log (ln)-transformed, specific gravity (SG)-adjusted first trimester (T1) and average of T1 and third trimester (T3) ("T1T3avg") phthalate metabolite concentrations. We fit linear regression models to examine the percent change in blood glucose per IQR increase in ln-transformed, SG-adjusted T1 and T1T3avg phthalates. In sensitivity analyses, we examined interactions between exposure and race. We adjusted for maternal age, maternal body mass index, study center, race/ethnicity, parity, and gestational age at glucose testing. RESULTS: In our sample of 705 pregnant women, we observed 60 cases of GDM, 90 cases of IGT, and an average GLT blood glucose of 113.6 ± 27.7 mg/dL. In our primary analysis, T1T3avg MEP was positively associated with GDM ([OR (95% CI) per IQR increase] T1T3avg MEP: 1.61 (1.10, 2.36)). In secondary analyses, most other phthalates were not found to be related to study outcomes, though some associations were noted. Sensitivity analyses indicated possible strong race-specific associations in Asians, though these results are based on a small sample size (n = 35). CONCLUSION: In alignment with our a priori selection, we documented an association between T1T3avg MEP and GDM. Additional phthalate metabolites were also found to be linked to glucose intolerance, with possible stronger associations in certain racial/ethnic subgroups. Given the prevalence of phthalate exposures and the growing evidence of associations with metabolic outcomes, future studies should continue to examine this question in diverse cohorts of pregnant women, particularly in those who may be at higher risk for GDM and IGT.
BACKGROUND:Phthalates are common plasticizer chemicals that have been linked to glucose intolerance in the general population, but there is only limited research on their association with gestational diabetes (GDM). OBJECTIVE: We evaluated the association between 11 urinary phthalate metabolites and GDM, impaired glucose tolerance (IGT), and continuous blood glucose concentration during pregnancy in The Infant Development and Environment Study (TIDES). Based on prior study results, our primary analyses focused on monoethyl phthalate (MEP) in relation to our outcomes of interest. STUDY DESIGN: We used multi-variable logistic regression to examine the odds of GDM and IGT in relation to an interquartile-range (IQR) increase in natural log (ln)-transformed, specific gravity (SG)-adjusted first trimester (T1) and average of T1 and third trimester (T3) ("T1T3avg") phthalate metabolite concentrations. We fit linear regression models to examine the percent change in blood glucose per IQR increase in ln-transformed, SG-adjusted T1 and T1T3avg phthalates. In sensitivity analyses, we examined interactions between exposure and race. We adjusted for maternal age, maternal body mass index, study center, race/ethnicity, parity, and gestational age at glucose testing. RESULTS: In our sample of 705 pregnant women, we observed 60 cases of GDM, 90 cases of IGT, and an average GLT blood glucose of 113.6 ± 27.7 mg/dL. In our primary analysis, T1T3avg MEP was positively associated with GDM ([OR (95% CI) per IQR increase] T1T3avg MEP: 1.61 (1.10, 2.36)). In secondary analyses, most other phthalates were not found to be related to study outcomes, though some associations were noted. Sensitivity analyses indicated possible strong race-specific associations in Asians, though these results are based on a small sample size (n = 35). CONCLUSION: In alignment with our a priori selection, we documented an association between T1T3avg MEP and GDM. Additional phthalate metabolites were also found to be linked to glucose intolerance, with possible stronger associations in certain racial/ethnic subgroups. Given the prevalence of phthalate exposures and the growing evidence of associations with metabolic outcomes, future studies should continue to examine this question in diverse cohorts of pregnant women, particularly in those who may be at higher risk for GDM and IGT.
Authors: Selma H Bouthoorn; Lindsay M Silva; Sheila E Murray; Eric A P Steegers; Vincent W V Jaddoe; Henriette Moll; Albert Hofman; Johan P Mackenbach; Hein Raat Journal: Acta Diabetol Date: 2014-10-26 Impact factor: 4.280
Authors: Yan Song; Elizabeth L Chou; Aileen Baecker; Nai-Chieh Y You; Yiqing Song; Qi Sun; Simin Liu Journal: J Diabetes Date: 2015-09-01 Impact factor: 4.006
Authors: Shelley Ehrlich; Donna Lambers; Andrea Baccarelli; Jane Khoury; Maurizio Macaluso; Shuk-Mei Ho Journal: Am J Perinatol Date: 2016-08-04 Impact factor: 1.862
Authors: Boyd E Metzger; Lynn P Lowe; Alan R Dyer; Elisabeth R Trimble; Udom Chaovarindr; Donald R Coustan; David R Hadden; David R McCance; Moshe Hod; Harold David McIntyre; Jeremy J N Oats; Bengt Persson; Michael S Rogers; David A Sacks Journal: N Engl J Med Date: 2008-05-08 Impact factor: 91.245
Authors: Susan Y Chu; William M Callaghan; Shin Y Kim; Christopher H Schmid; Joseph Lau; Lucinda J England; Patricia M Dietz Journal: Diabetes Care Date: 2007-04-06 Impact factor: 19.112
Authors: Elizabeth E Hatch; Jessica W Nelson; M Mustafa Qureshi; Janice Weinberg; Lynn L Moore; Martha Singer; Thomas F Webster Journal: Environ Health Date: 2008-06-03 Impact factor: 5.984
Authors: William C Hsu; Maria Rosario G Araneta; Alka M Kanaya; Jane L Chiang; Wilfred Fujimoto Journal: Diabetes Care Date: 2015-01 Impact factor: 19.112
Authors: Emily S Barrett; Matthew Corsetti; Drew Day; Sally W Thurston; Christine T Loftus; Catherine J Karr; Kurunthachalam Kannan; Kaja Z LeWinn; Alicia K Smith; Roger Smith; Frances A Tylavsky; Nicole R Bush; Sheela Sathyanarayana Journal: Environ Int Date: 2022-01-07 Impact factor: 9.621
Authors: Emma V Preston; Sheryl L Rifas-Shiman; Marie-France Hivert; Ami R Zota; Sharon K Sagiv; Antonia M Calafat; Emily Oken; Tamarra James-Todd Journal: J Clin Endocrinol Metab Date: 2020-08-01 Impact factor: 5.958
Authors: Haotian Wu; Allison J Kupsco; Andrea L Deierlein; Allan C Just; Antonia M Calafat; Emily Oken; Joseph M Braun; Adriana Mercado-Garcia; Alejandra Cantoral; Martha M Téllez-Rojo; Robert O Wright; Andrea A Baccarelli Journal: Environ Sci Technol Date: 2020-01-24 Impact factor: 9.028